Join Innate Pharma for an in-person investor and analyst event to discuss lacutamab, a Phase 3 ready asset. The program…
Join SELLAS Life Sciences Group for a virtual R&D Day featuring key opinion leaders (KOLs), alongside company management, to discuss…
Join Foghorn Therapeutics for a virtual investor event to review key development updates for its Selective ARID1B degrader program which will…

Join Equillium for a virtual key opinion leader (KOL) event where management will be joined by experts in their fields, Francisco…
Join Atea Pharmaceuticals for a virtual panel discussion featuring several hepatitis C (HCV) key opinion leaders (KOLs) including: Jordan Feld,…

Join Ligand Pharmaceuticals for its annual Investor Day featuring presentations from Ligand CEO Todd Davis, CFO Tavo Espinoza and other members of…